Possible interaction between activator protein-1 and proto-oncogene B-cell lymphoma gene 6 in breast cancer patients resistant to tamoxifen
- 1 January 2004
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 63 (5), 823-826
- https://doi.org/10.1016/j.mehy.2004.03.026
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Markers of increased risk for failure of adjuvant therapiesThe Breast, 2003
- Aromatase inhibitors for breast cancer: lessons from the laboratoryNature Reviews Cancer, 2003
- Antiestrogen resistance in breast cancer and the role of estrogen receptor signalingOncogene, 2003
- Prognostic and Predictive Indicators in Operable Breast CancerClinical Breast Cancer, 2003
- Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growthOncogene, 2002
- Selective Estrogen Receptor Modulators: Structure, Function, and Clinical UseJournal of Clinical Oncology, 2000
- cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotypeOncogene, 1999
- Steroid hormone receptors in breast cancer managementBreast Cancer Research and Treatment, 1998
- Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 SitesScience, 1997
- Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogensMolecular Endocrinology, 1995